Blood-pool imaging using technetium-99m-labeled liposomes

Journal of Nuclear Medicine

Volumn 37, Issue 8, 1996, Pages 1374-1379

  Goins, Beth ^a   Phillips, William T ^a   Klipper, Robert ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

blood pool imaging; liposomes; polyethylene glycol; technetium 99m HMPAO; technetium 99m liposomes; ventriculography

Indexed keywords

ERYTHROCYTE TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LIPOSOME TC 99M; MACROGOL; SERUM ALBUMIN TC 99M;

ANIMAL EXPERIMENT; ARTICLE; BLOOD; DIAGNOSTIC IMAGING; ERYTHROCYTE; HEART VENTRICULOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ERYTHROCYTES; GATED BLOOD-POOL IMAGING; HEART; ISOTOPE LABELING; LIPOSOMES; LIVER; LUNG; MALE; ORGANOTECHNETIUM COMPOUNDS; OXIMES; POLYETHYLENE GLYCOLS; RABBITS; TECHNETIUM; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M EXAMETAZIME; TISSUE DISTRIBUTION; URINARY BLADDER;

EID: 0029778094     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chilton HM, Callahan RJ, Thrall JH. Radiopharmaceuticals for cardiac imaging: myocardial infarction, perfusion, metabolism and ventricular function (blood pool). In: Swanson DP, Chilton HM, Thrall JH, eds. Pharmaceuticals in medical imaging. New York: Macmillan; 1990:419-461.
2. Verbeke KA, Vanbilloen HP, DeRoo MJ, Verbruggen AM. Technetium-99m mercaptoalbumin as a potential substitute for technetium-99m-labeled red blood cells. Eur J Nucl Med 1993,20:473-482.
3. Verbeke KA, Vanhecke WB, Mortelmans LA, Verbruggen AM. First evaluation of technetium-99m dimercaptopropionyl albumin as a possible tracer agent for ventriculography in a volunteer. Eur J Nucl Med 1994;21:906-912.
4. Bogdanov AA Jr, Callahan RJ, Wilkinson RA, et al. Synthetic copolymer kit for radionuclide blood-pool imaging. J Nucl Med 1994;35:1880-1886.
5. Tilcock C, Utkhede D, Lyster D, Coupland D, Szasz I. Development and evaluation of a new blood-pool imaging agent. Eur J Nucl Med 1994;21:S7.
6. Woodle MC. Gallium-67-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents. Nucl Med Biol 1993;20:149-155.
7. Phillips WT, Rudolph AS, Goins B, et al. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl Med Biol 1992;19: 539-547.
8. Goins B, Klipper R, Rudolph AS, et al. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J Nucl Med 1993;34: 2160-2168.
9. Goins B, Klipper R, Rudolph AS, Phillips WT. Use of technetium-99m-liposomes in tumor imaging. J Nucl Med 1994;35:1491-1498.
10. Stewart JCM. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 1980;104:10-14.
11. Scherphof GL. In vivo behavior of liposomes: interactions with mononuclear phagocyte system and implications for drug targeting. In: Juliano RL, ed. Targeted drug delivery. New York: Springer-Verlag, 1991:285-327.
12. Hambye AS, Vandermeiren R, Vervaet A, Vandevivere J. Failure to label red blood cells adequately in daily practice using an in vivo method: methodological and clinical considerations. Eur J Nucl Med 1995;22:61-67.
13. 99mTc-recombinant human serum albumin (rHSA): a new generation of radiopharmaceutical. Eur J Nucl Med 1994;21:1231-1233.
14. Caride VJ. Technical and biological considerations in the use of radiolabeled liposomes for diagnostic imaging. Nucl Med Biol 1990;17:35-39.
15. Lasic D. Liposomes. American Scientist 1992;80:20-31.
16. 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanolamine (DTTA). Nucl Med Biol 1992;19:831-840.
17. Tilcock C, Ahkong QF, Fisher D. Technetium-99m-labeling of lipid vesicles containing the lipophilic chelator PE-DTTA: effect of tin-to-chelate ratio, chelate content and surface polymer on labeling efficiency and biodistribution behavior. Nucl Med Biol 1994;21:89-96.